Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Genscript Biotech Corp

Current Assets 2.4B
Cash & Short-Term Investments 1.9B
Receivables 299.5m
Other Current Assets 125.5m
Non-Current Assets 1B
Long-Term Investments 90.8m
PP&E 750.9m
Intangibles 20m
Other Non-Current Assets 172.4m
Current Liabilities 494.8m
Accounts Payable 40m
Accrued Liabilities 165.9m
Short-Term Debt 56.9m
Other Current Liabilities 232m
Non-Current Liabilities 1.5B
Long-Term Debt 351.1m
Other Non-Current Liabilities 1.2B

Balance Sheet
Genscript Biotech Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
23
26
104
136
124
495
252
629
1 181
1 024
Cash
0
0
0
0
73
107
240
514
0
0
Cash Equivalents
23
26
104
136
51
388
12
115
1 181
1 024
Short-Term Investments
4
3
3
0
3
70
174
142
222
439
Total Receivables
9
13
26
21
260
83
88
166
167
172
Accounts Receivables
9
12
17
19
254
65
70
137
135
97
Other Receivables
0
1
9
2
6
17
18
29
32
75
Inventory
1
2
2
4
7
12
20
32
44
60
Other Current Assets
1
1
1
2
4
20
20
25
24
69
Total Current Assets
39
44
133
164
398
679
554
993
1 639
1 765
PP&E Net
39
38
38
46
83
162
274
385
505
647
PP&E Gross
39
38
38
46
83
162
274
385
505
647
Accumulated Depreciation
12
16
0
23
27
36
52
81
108
143
Intangible Assets
0
0
1
2
2
20
25
26
26
24
Goodwill
0
0
0
1
1
15
15
14
14
3
Long-Term Investments
0
0
0
0
2
11
15
22
25
23
Other Long-Term Assets
6
11
10
13
18
29
6
7
23
85
Other Assets
0
0
0
1
1
15
15
14
14
3
Total Assets
84
N/A
92
+10%
182
+97%
226
+24%
504
+123%
917
+82%
889
-3%
1 447
+63%
2 234
+54%
2 546
+14%
Liabilities
Accounts Payable
12
14
2
4
8
11
18
23
30
56
Accrued Liabilities
6
8
8
16
14
37
89
114
156
210
Short-Term Debt
0
0
0
0
0
11
16
44
0
33
Current Portion of Long-Term Debt
0
0
0
0
0
0
2
3
8
12
Other Current Liabilities
12
8
18
18
89
95
99
143
219
235
Total Current Liabilities
30
29
31
39
112
154
225
328
413
546
Long-Term Debt
0
0
0
0
0
0
5
8
148
305
Deferred Income Tax
0
0
0
0
0
4
6
7
8
8
Minority Interest
0
0
0
6
11
15
11
86
342
352
Other Liabilities
1
1
2
2
163
266
282
289
277
325
Total Liabilities
31
N/A
31
-2%
33
+7%
48
+48%
286
+490%
438
+54%
507
+16%
546
+8%
1 188
+118%
1 536
+29%
Equity
Common Stock
0
0
2
2
2
2
2
2
2
2
Retained Earnings
48
58
43
70
96
125
37
156
235
428
Additional Paid In Capital
0
0
0
118
121
364
369
1 067
1 274
1 473
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
8
17
16
12
Other Equity
4
4
4
12
0
12
17
6
20
25
Total Equity
53
N/A
62
+18%
149
+142%
178
+19%
219
+23%
479
+119%
383
-20%
902
+136%
1 046
+16%
1 011
-3%
Total Liabilities & Equity
84
N/A
92
+10%
182
+97%
226
+24%
504
+123%
917
+82%
889
-3%
1 447
+63%
2 234
+54%
2 546
+14%
Shares Outstanding
Common Shares Outstanding
1 200
1 200
1 600
1 692
1 734
1 835
1 878
1 953
2 096
2 111

See Also

Discover More